Valuation : IRIDEX Corporation

Market Cap 12.31M 10.59M 9.94M 9.09M 16.97M 1.16B 17.1M 118M 45.78M 595M 46.22M 45.21M 1.91B P/E 2026 *
-5.84x
P/E 2027 * -
Enterprise Value 12.31M 10.59M 9.94M 9.09M 16.97M 1.16B 17.1M 118M 45.78M 595M 46.22M 45.21M 1.91B EV / Sales 2026 *
0.23x
EV / Sales 2027 * 0.22x
Free-Float
61.18%
Yield 2026 *
-
Yield 2027 * -
1 day-2.83%
1 week-1.63%
Current month-3.16%
1 month-15.07%
3 months-39.07%
6 months-51.00%
Current year-38.54%
1 week 0.7
Extreme 0.7
0.74
1 month 0.7
Extreme 0.6985
0.98
Current year 0.7
Extreme 0.6985
1.65
1 year 0.7
Extreme 0.6985
1.65
3 years 0.7
Extreme 0.6985
3.65
5 years 0.7
Extreme 0.6985
9.46
10 years 0.7
Extreme 0.6985
16.39
Manager TitleAgeSince
Chief Executive Officer 54 30/09/2024
Director of Finance/CFO 68 17/12/2018
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 23/06/2020
Director/Board Member 54 31/08/2018
Director/Board Member 66 16/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
24/08/26 Buy

Chief Financial Officer

6,668 0.0383%
10/07/26 Free

Chief Financial Officer

200,000 1.1490%
10/07/26 Free

Chief Executive Officer

400,000 2.2980%
Change 5-day change 1-year change 3-year change Capi.($)
-2.83%-1.63%-49.41%-60.75% 12.31M
+1.63%-1.95%+27.63%+10.98% 229B
+0.53%-2.16%+5.81%-20.54% 148B
-0.55%+0.75%-16.17%+19.14% 131B
-2.94%+0.60%-56.34%-12.44% 68.04B
-1.15%-0.19%+10.54%+17.54% 51.75B
-1.65%-1.15%-16.82%-15.26% 50.21B
-0.93%-4.89%+19.77%+23.03% 42.28B
+0.33%-1.83%+42.58%+47.16% 40.63B
-0.73%-2.79%-14.87%+43.97% 33.06B
Average -0.62%-1.02%-4.73%+5.28% 79.37B
Weighted average by Cap. +0.12%-1.78%+3.79%+7.06%

Financials

2026 *2027 *
Net sales 52.52M 45.19M 42.41M 38.8M 72.41M 4.96B 72.99M 502M 195M 2.54B 197M 193M 8.17B 55.98M 48.16M 45.2M 41.35M 77.18M 5.29B 77.79M 535M 208M 2.7B 210M 206M 8.71B
Net income -2.09M -1.79M -1.68M -1.54M -2.88M -197M -2.9M -19.92M -7.76M -101M -7.83M -7.66M -325M 1K 860.4 807.42 738.72 1.38K 94.53K 1.39K 9.55K 3.72K 48.31K 3.76K 3.67K 156K
Net Debt - -
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
03/09/26 US$0.7007 -2.83% 70,141
02/09/26 US$0.7211 -1.19% 14,813
01/09/26 US$0.7298 +0.86% 26,838
31/08/26 US$0.7236 +2.42% 28,463
28/08/26 US$0.7065 -0.81% 98,979
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.7007USD
Average target price
2.750USD
Spread / Average Target
+292.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRIX Stock